Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Ritalin (methylphenidate hydrochloride) and Ritalin LA (methylphenidate hydrochloride) - Important Safety Information from Novartis as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
11/09/2006
Problem Or Issue:
Ritalin (methylphenidate hydrochloride) and Ritalin LA (methylphenidate hydrochloride) - Please find attached Important Safety Communication from Novartis in respect of Ritalin 10mg Tablets, Ritalin LA 20mg prolonged-release capsules, Ritalin LA 30mg prolonged-release capsules, Ritalin LA 40mg prolonged-release capsules.
« Back
Date Printed: 25/04/2024